Lv11
30 积分 2023-05-10 加入
Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer
4小时前
待确认
Trends in the approval of cancer therapies by the FDA in the twenty-first century
1个月前
已完结
Rational combinations of targeted cancer therapies: background, advances and challenges
1个月前
已完结
Remodelling of the translatome controls diet and its impact on tumorigenesis
2个月前
已完结
Discovering the anticancer potential of non-oncology drugs by systematic viability profiling
3个月前
已完结
Mechanisms of response and tolerance to active RAS inhibition in KRAS-mutant NSCLC
3个月前
已完结
A protein expression atlas on tissue samples and cell lines from cancer patients provides insights into tumor heterogeneity and dependencies
3个月前
已完结
Combined JAK inhibition and PD-1 immunotherapy for non–small cell lung cancer patients
4个月前
已完结
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
4个月前
已完结
Mapping the proximity interaction network of the Rho-family GTPases reveals signalling pathways and regulatory mechanisms
4个月前
已完结
皖公网安备34019202002308
